Literature DB >> 10204711

A simplified and standardized neutralization enzyme immunoassay for the quantification of measles neutralizing antibody.

M S Lee1, B Cohen, J Hand, D J Nokes.   

Abstract

A simplified and standardized neutralization enzyme immunoassay (Nt-EIA) was developed to detect measles virus growth in Vero cells and to quantify measles neutralizing antibody. Heat-inactivated sera were diluted serially 4-fold and tested in duplicate. The 50% reduction point (50%RP) of virus growth was calculated using the Reed-Muench formula and the neutralizing antibody titre of test sera was converted into mIU/ml by comparing their 50%RP with that of the international standard serum. The optimal virus input and incubation time were found to be 50-100 plaque forming unit (PFU)/well and 64-72 h, respectively. The simplified Nt-EIA had a good reproducibility with only 3.7-4.2% of duplicate tests having a ratio > 4 in an evaluation of intra assay variation and the coefficients of variance were 2-9% in an evaluation of inter assay variation. In addition, the simplified Nt-EIA had a high sensitivity(98.6%), specificity (100%) and agreement (98.8%) in qualitative comparison with plaque reduction neutralization test (PRNT). In quantitative comparison, the correlation coefficient between Nt-EIA and PRNT was 0.83 without log transformation or 0.77 after log transformation and 90% of 61 positive sera had a ratio < 4 between antibody titre tested by the two methods. The simplified Nt-EIA is thus a suitable alternative to the PRNT for the quantification of measles neutralizing antibody.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10204711     DOI: 10.1016/s0166-0934(98)00178-5

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  11 in total

1.  Dual-reporter Imaging and its Potential Application in Tracking Studies.

Authors:  Jie Ding; Chao Wang; Pei-Cheng Li; Zhen Zhao; Cheng Qian; Cong-Xiao Wang; Yu Cai; Gao-Jun Teng
Journal:  J Fluoresc       Date:  2016-01       Impact factor: 2.217

2.  Comparison of the neutralizing and ELISA antibody titres to measles virus in human sera and in gamma globulin preparations.

Authors:  Holger F Rabenau; Branko Marianov; Sabine Wicker; Regina Allwinn
Journal:  Med Microbiol Immunol       Date:  2007-02-17       Impact factor: 3.402

3.  Immunogenicity of an inactivated novel goose parvovirus vaccine for short beak and dwarfism syndrome in Cherry Valley ducks.

Authors:  Jiewen Zhou; Chuanfeng Li; Aoxing Tang; Hang Li; Zhaorong Yu; Zongyan Chen; Xin Guo; Guangqing Liu
Journal:  Arch Virol       Date:  2022-02-11       Impact factor: 2.574

4.  Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles virus immunity.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; Robert A Vierkant; Gregory A Poland
Journal:  Clin Vaccine Immunol       Date:  2008-05-07

5.  Seroprevalence of neutralizing antibodies to measles virus in a vaccinated population in Iran, 1998.

Authors:  Mazaher Khodabandeh Loo; Farzaneh Sabahi; Horieh Soleimanjdahi; Anooshirvan Kazemnejad; Mohammod Hassan Roustai
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

6.  Predicting antigenic variants of influenza A/H3N2 viruses.

Authors:  Min-Shi Lee; Jack Si-En Chen
Journal:  Emerg Infect Dis       Date:  2004-08       Impact factor: 6.883

7.  Measles-based Zika vaccine induces long-term immunity and requires NS1 antibodies to protect the female reproductive tract.

Authors:  Drishya Kurup; Christoph Wirblich; Rachael Lambert; Leila Zabihi Diba; Benjamin E Leiby; Matthias J Schnell
Journal:  NPJ Vaccines       Date:  2022-04-19       Impact factor: 9.399

8.  Comparison of JEV neutralization assay using pseudotyped JEV with the conventional plaque-reduction neutralization test.

Authors:  Hee-Jung Lee; Kyung-Il Min; Ki Hoon Park; Hyo Jung Choi; Min-Kyoung Kim; Chi-Young Ahn; Young-Jin Hong; Young Bong Kim
Journal:  J Microbiol       Date:  2014-03-07       Impact factor: 3.422

Review 9.  Evaluation of the effect of maternally derived antibody on response to MMR vaccine in Thai infants.

Authors:  Siyuan Hu; Nicola Logan; Jiratchaya Puenpa; Nasamon Wanlapakorn; Sompong Vongpunsawad; Yong Poovorawan; Brian J Willett; Margaret J Hosie
Journal:  Vaccine       Date:  2022-02-05       Impact factor: 3.641

10.  Comparing molecular methods for early detection and serotyping of enteroviruses in throat swabs of pediatric patients.

Authors:  Pai-Shan Chiang; Mei-Liang Huang; Shu-Ting Luo; Tzou-Yien Lin; Kuo-Chien Tsao; Min-Shi Lee
Journal:  PLoS One       Date:  2012-10-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.